Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions
Clinical Obesity · 2025-04 · 15 (2)
DOI: 10.1111/cob.12725 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Obesity, online erschienen am 02.12.2024. Verfasst von Robin Lengton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Obesity, Glucocorticoids. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and obesity. We discuss three biological stress systems—the autonomic nervous system, the hypothalamus–pituitary–adrenal (HPA) axis and the immune system—and their link with obesity, with a particular focus on the HPA axis. The role of cortisol and its regulatory variations (including glucocorticoid rhythmicity and altered sensitivity) in adipose tissue biology and obesity development is discussed. Moreover, we highlight the physiological, affective, cognitive and behavioural dimensions of the stress response offering a deeper understanding of how stress contributes to obesity development and vice versa. Finally, stress as a treatment target for obesity is discussed. We conclude that the link between stress and obesity is complex and multifaceted, influenced by physiological, affective, cognitive and behavioural stress response mechanisms, which especially when chronically present, play a key role in the development of obesity and associated cardiometabolic diseases. This necessitates integrated approaches tailored to individual needs, including lifestyle modifications, behavioural interventions, psychosocial support and possible additional pharmacological interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Biological Psychology, Vrije Universiteit, Amsterdam, The Netherlands.
- Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, The Netherlands.
- Department of Psychiatry and Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
ORCID-Profile: Robin Lengton, Myrte Schoenmakers, Brenda W J H Penninx, Mariëtte R Boon, Elisabeth F C van Rossum
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Lengton, R., Schoenmakers, M., Penninx, B. W. J. H., Boon, M. R., & van Rossum, E. F. C. (2025). Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions. Clinical Obesity, 15(2). https://doi.org/10.1111/cob.12725
Vancouver
Lengton R, Schoenmakers M, Penninx BWJH, Boon MR, van Rossum EFC. Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions. Clinical Obesity. 2025;15(2). doi:10.1111/cob.12725
BibTeX
@article{Lengton2025,
author = {Lengton, Robin and Schoenmakers, Myrte and Penninx, Brenda W J H and Boon, Mariëtte R and van Rossum, Elisabeth F C},
title = {Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions},
journal = {Clinical Obesity},
year = {2025},
volume = {15},
number = {2},
doi = {10.1111/cob.12725}
}
EUVIMED